Since our glycomics provides a relative assessment of glycans, we sought to explore the oligomannose levels in cancer samples using the Galanthus Nivalis Lectin (GNL), which primarily targets the terminal α1-3-mannose and α1-6-mannose structures that are abundantly present in oligomannosidic glycans [21,22,23]. Here, RGN is linked to cancer.